Notice Number: NOT-HL-18-621
Key Dates
Release Date: July 9, 2018
Issued by
National Heart, Lung, and Blood Institute (NHLBI)
Purpose
The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating in PA-17-444 "Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)" effective immediately.
The following sections of PA-17-444 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA):
Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.172; 93.399; 93.307; 93.173; 93.853; 93.866; 93.113; 93.865; 93.233; 93.837; 93.838; 93.839; 93.840
The NHLBI is interested in applications that address the ethical, legal, and social issues arising from genomic research on heart, lung, blood, and sleep diseases and disorders. In addition, the NHLBI is especially interested in applications that address ELSI topics relevant to its Strategic Vision. Guidance about NHLBI's specific ELSI research priorities is forthcoming and will be posted on the NHGRI's ELSI Research Domains website. For additional scientific program information and for pre-application guidance, potential applicants are encouraged to contact the NHLBI Scientific/Research Contact listed in Section VII. Agency Contacts.
Inquiries
Please direct all inquiries to:
Mollie Minear, Ph.D.
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0448
Email: [email protected]